These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 31266868

  • 1. Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III.
    Messinger JE, Dai J, Stanland LJ, Price AM, Luftig MA.
    mBio; 2019 Jul 02; 10(4):. PubMed ID: 31266868
    [Abstract] [Full Text] [Related]

  • 2. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM, Messinger JE, Luftig MA.
    J Virol; 2018 Jan 15; 92(2):. PubMed ID: 29118124
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
    Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E.
    J Virol; 2004 Apr 15; 78(8):4108-19. PubMed ID: 15047827
    [Abstract] [Full Text] [Related]

  • 6. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY, Chou YC, Lin JH, Liu Y, Lin KM, Doong SL, Chen MR, Yeh TH, Lin SJ, Tsai CH.
    J Virol; 2015 Jun 15; 89(11):5968-80. PubMed ID: 25810549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
    Bristol JA, Nelson SE, Ohashi M, Casco A, Hayes M, Ranheim EA, Pawelski AS, Singh DR, Hodson DJ, Johannsen EC, Kenney SC.
    PLoS Pathog; 2024 Apr 15; 20(4):e1012132. PubMed ID: 38620028
    [Abstract] [Full Text] [Related]

  • 9. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD, Tsai MH, Romero-Masters JC, Ranheim EA, Huebner SM, Bristol JA, Delecluse HJ, Kenney SC.
    J Virol; 2017 Apr 01; 91(7):. PubMed ID: 28077657
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB.
    Proc Natl Acad Sci U S A; 2006 Oct 03; 103(40):14935-40. PubMed ID: 17001014
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
    Xu WS, Chan AC, Lee JM, Liang RH, Ho FC, Srivastava G.
    J Med Virol; 1998 Dec 03; 56(4):342-50. PubMed ID: 9829640
    [Abstract] [Full Text] [Related]

  • 13. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD, Lupey-Green LN, Biryukov S, Hughes DJ, Marendy EM, Miranda JL, Sample JT.
    J Virol; 2020 Aug 17; 94(17):. PubMed ID: 32581094
    [Abstract] [Full Text] [Related]

  • 14. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
    Pich D, Mrozek-Gorska P, Bouvet M, Sugimoto A, Akidil E, Grundhoff A, Hamperl S, Ling PD, Hammerschmidt W.
    mBio; 2019 Sep 17; 10(5):. PubMed ID: 31530670
    [Abstract] [Full Text] [Related]

  • 15. LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.
    Zhang J, Sommermann T, Li X, Gieselmann L, de la Rosa K, Stecklum M, Klein F, Kocks C, Rajewsky K.
    Front Immunol; 2023 Sep 17; 14():1331730. PubMed ID: 38169736
    [Abstract] [Full Text] [Related]

  • 16. A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latency.
    Yan B, Wang C, Chakravorty S, Zhang Z, Kadadi SD, Zhuang Y, Sirit I, Hu Y, Jung M, Sahoo SS, Wang L, Shao K, Anderson NL, Trujillo-Ochoa JL, Briggs SD, Liu X, Olson MR, Afzali B, Zhao B, Kazemian M.
    J Med Virol; 2023 Jan 17; 95(1):e28362. PubMed ID: 36453088
    [Abstract] [Full Text] [Related]

  • 17. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
    Brink AA, Dukers DF, van den Brule AJ, Oudejans JJ, Middeldorp JM, Meijer CJ, Jiwa M.
    J Clin Pathol; 1997 Nov 17; 50(11):911-8. PubMed ID: 9462239
    [Abstract] [Full Text] [Related]

  • 18. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J.
    J Virol; 2009 May 17; 83(10):5014-27. PubMed ID: 19264782
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E.
    J Virol; 2015 Dec 30; 90(6):2906-19. PubMed ID: 26719268
    [Abstract] [Full Text] [Related]

  • 20. Targeting latent viral infection in EBV-associated lymphomas.
    Kong IY, Giulino-Roth L.
    Front Immunol; 2024 Dec 30; 15():1342455. PubMed ID: 38464537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.